Vaccibody successfully completes a 35 million NOK financing

Vaccibody has in a new share issue completed a 35 MNOK (4.3 million €) financing from existing and new investors. The share issue was significantly oversubscribed. The largest new investor is represented by Datum and partners, which will take a seat in the Board of Directors. Arctic Securities is the manager for the share issue. […]

Ketil Widerberg on Pharma TV

In April 2014, Pharma TV interviewed Ketil Widerberg, General Manager of Oslo Cancer Cluster. Watch the interview and learn more about how Oslo Cancer Cluster works to develop new diagnostics and medication. Watch the interview here. In the interview Ketil Widerberg also explains to Fintan Walton from Pharma TV how Oslo Cancer Cluster`s core expertise […]

Protecting oncology innovations – download presentations

Researchers, clinicians and start-ups filled up the seminar room when Oslo Cancer Cluster Incubator together with the Norwegian Industrial Property Office (Patentstyret) and Inven2 invited to a breakfast meeting on June 18th. The breakfast seminar had a special focus on protecting oncology innovations.   Some take-home-messages from the seminar: Patents give you negotiation power, and […]

850 MNOK to innovation projects

The Norwegian Research Council will grant NOK 850 million to industry innovation projects – the largest grant of its kind in history. Application deadline is October 15, 2014. The Research Council recently launched a website with all relevant information on this funding scheme. Ketil Widerberg, General Manager of Oslo Cancer Cluster says: “Funding for the […]